{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T13:03:45Z","timestamp":1769519025290,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.neuroscience.2011.08.064","type":"journal-article","created":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T06:19:23Z","timestamp":1314857963000},"page":"124-130","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Preclinical pharmacology of TP1, a novel potent triple reuptake inhibitor with antidepressant properties"],"prefix":"10.1016","volume":"196","author":[{"given":"J.-W.","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.-L.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Gai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-B.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.-X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2011.08.064_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/026988110201600403","article-title":"Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study","volume":"16","author":"Beyer","year":"2002","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.euroneuro.2008.07.011","article-title":"The triple monoaminergic reuptake inhibitor DOV 216,303 has antidepressant effects in the rat olfactory bulbectomy model and lacks sexual side effects","volume":"18","author":"Breuer","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib3","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","article-title":"Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors","volume":"25","author":"Bymaster","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1124\/jpet.110.174011","article-title":"The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties","volume":"335","author":"Caldarone","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-2999(00)00566-5","article-title":"The role of dopamine in the mechanism of action of antidepressant drugs","volume":"405","author":"D'Aquila","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/jpet.106.103382","article-title":"Desvenlafaxine succinate: a new serotonin and norepinephrine reuptake inhibitor","volume":"318","author":"Deecher","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib9","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0022-3565(24)38214-X","article-title":"Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type","volume":"289","author":"Eshleman","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib10","first-page":"402","article-title":"Animal models for better antidepressants: can pathogenetic approaches make a difference?","volume":"2","author":"Harro","year":"2004","journal-title":"Preclinica"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrd2468","article-title":"Prodrugs: design and clinical applications","volume":"7","author":"Rautio","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.appet.2009.07.018","article-title":"Dopamine\/adenosine interactions involved in effort-related aspects of food motivation","volume":"53","author":"Salamone","year":"2009","journal-title":"Appetite"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2006.10.004","article-title":"Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050","volume":"555","author":"Shaw","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1527-3458.2006.00123.x","article-title":"Preclinical and clinical pharmacology of DOV 216, 303, a \u201ctriple\u201d reuptake inhibitor. CNS","volume":"12","author":"Skolnick","year":"2006","journal-title":"Drug Rev"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(03)01310-4","article-title":"Antidepressant-like actions of DOV 21,947: a \u201ctriple\u201d reuptake inhibitor","volume":"461","author":"Skolnick","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/00004714-200302000-00011","article-title":"Dual monoamine modulation for improved treatment of major depressive disorder","volume":"23","author":"Tran","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib19","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/35072566","article-title":"Research and treatment approaches to depression","volume":"2","author":"Wong","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2011.08.064_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.biopsych.2005.06.027","article-title":"Use of bupropion in combination with serotonin reuptake inhibitors","volume":"59","author":"Zisook","year":"2006","journal-title":"Biol Psychiatry"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452211010220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452211010220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T15:22:42Z","timestamp":1741533762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452211010220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":20,"alternative-id":["S0306452211010220"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2011.08.064","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}